Triamcinolone

From Anvita Health Wiki

Jump to: navigation, search

Contents

Introduction

  • Systemic agent: Tradenames: Aristocort, Kenacort, Kenalog.

Indications

Contraindications

Dosage

  • Tabs: 1, 2, 4, 8 mg
  • Syrup: 4 mg/5 mL.
  • Injection: Kenalog, Trivaris
  • Cream: 0.025%, 0.1%, 0.5%.
  • Ointment: 0.025% (15 & 80 g), 0.1% (15, 60, 240 g), 0.5% (15 g).
  • Lotion: 0.025% (60 mL), 0.1% (15 mL, 60 mL). Paste 0.1% (Kenalog in Orabase)
  • Medium potency (0.025%). Inhaler: 100 ug/spray (20 g)

Adverse-effects

  • common (> 10%)
  • less common (1-10%)
  • uncommon (< 1%)
  • short-term
  • long-term
  • Azmacort:
  • Nasocort:

Drug-interactions

Mechanism-of-action

More General Terms

Internet Database

PubChem: 31307
PubChem: 5544
PubChem: 6216
PubChem: 6436
PubChem: 21826
PubChem: 62963
PubChem: 62964
PubChem: 633097
PubChem: 539244
PubChem: 16147
PubChem: 633091
PubChem: 5545
PubChem: 657338

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 85.
  3. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  4. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 743
  5. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  6. Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
  7. a) Journal Watch, Mass Med Soc 20(11):88 (June) 2000 b) Wong CA et al Lancet 355:1399, 2000 c) Sambrook PN Lancet 355:1385, 2000